Axonis Therapeutics Announces $115 Million Series A Financing Oct 30, 2024 06:00AM
venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies Aug 1, 2024 08:00AM
Form SC 13D/A Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund II L.P. Sep 15, 2022 05:02PM
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences Jun 3, 2021 08:00AM
Form SC 13D/A Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund II L.P. May 7, 2021 04:13PM


Sep 9, 2020 05:27PM Form SC 13D/A Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund II L.P.
Jul 8, 2020 03:58PM Form SC 13D/A Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund, L.P.
Apr 3, 2020 08:00AM venBio Closes $394 Million Life Sciences Venture Capital Fund
Mar 3, 2020 05:53PM Form 4 Akero Therapeutics, Inc. For: Feb 28 Filed by: venBio Global Strategic GP II, L.P.
Feb 10, 2020 05:48PM Form 4 Akero Therapeutics, Inc. For: Feb 06 Filed by: venBio Global Strategic GP II, L.P.
Jan 15, 2020 04:27PM Form SC 13D/A Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund II L.P.
Jan 6, 2020 04:08PM Form 4 Akero Therapeutics, Inc. For: Jan 02 Filed by: venBio Global Strategic GP II, L.P.
Jun 26, 2019 04:20PM Form SC 13D Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund II L.P.
Jun 25, 2019 09:21AM Form 4 Akero Therapeutics, Inc. For: Jun 24 Filed by: venBio Global Strategic GP II, Ltd.